From March 24 to 27, the Annual Conference of the Boao Forum for Asia (BFA) 2026, themed "Shaping a Shared Future: New Situations, New Opportunities, New Cooperation," grandly opened in Boao, Hainan. This year's conference coincides with the 25th anniversary of the Forum's establishment and is the first annual meeting after the full island-wide customs closure operation of the Hainan Free Trade Port. It gathered political leaders from multiple countries worldwide, heads of international organizations, business leaders, and top scholars to discuss new opportunities for global development and explore new paths for cross-border cooperation. As a leading domestic enterprise in the Brain-Computer Interface (BCI) + AI and VR digital healthcare sector, and a national-level Specialized, Refined, Differential, and Innovative "Little Giant" enterprise, Hangzhou NEUREAL Technology Co., Ltd. made a significant appearance at this year's conference with its independently developed core medical products at the high-standard exhibition on building the Hainan Free Trade Port. Leveraging its world-leading innovative achievements in digital brain disease diagnosis and treatment, it attracted numerous heavyweight international guests to stop for in-depth experiences, earning widespread praise and high recognition from the global political and business communities.
Live from the Scene
During the exhibition, the NEUREAL booth became a focal check-in spot for the medical technology segment of this year's conference. Its independently developed VR cognitive impairment treatment and VR psychotherapy systems, centered on BCI and AI, featured disruptive technical pathways, mature clinical application value, and ultimate immersive experiences. They served as a concrete example of innovation for the forum's "AI+Health" agenda, attracting successive visits and in-depth exchanges from political and business leaders and heads of international organizations from around the world.
Carlos Gutierrez, Member of the Board of Directors of the Boao Forum for Asia and Former U.S. Secretary of Commerce; Gilles Geu, First Vice President of the San Pedro Region of Côte d'Ivoire; Holger Binmann, Chairman of the German Chamber of Commerce and Vice Chairman of the Executive Committee of the International Chamber of Commerce; Bulgarbayev Yerbol, Head of the Association of Special Economic Zones of Kazakhstan; and Mr. Majid and Ms. Samir from the Economic Cooperation Organization (ECO), among other heavyweight international guests, successively visited the NEUREAL booth to immerse themselves in this original Chinese digital healthcare solution. During the experience, guests completed the entire process of emotional relief, cognitive training, and psychological intervention through customized VR diagnostic and therapeutic scenarios, personally feeling how digital technology revolutionizes traditional brain disease diagnosis and treatment models.
After the experience, many guests gave extremely high evaluations to the products, unanimously agreeing that NEUREAL's innovative achievements provide a replicable and scalable Chinese solution for the diagnosis and treatment of mental disorders and cognitive impairments globally. This not only breaks the geographical limitations and resource barriers of traditional diagnostic and treatment models but also significantly lowers the threshold for diagnosis and treatment and improves patient compliance, possessing both high clinical value and broad social inclusivity. Many guests expressed intentions for deep cooperation on-site, hoping to promote the local implementation of this technology and product in their countries in the future, contributing to the innovative development of local healthcare services.
Full-Process Diagnostic and Treatment Closed-Loop Products
The core products exhibited by NEUREAL this time are among the first batch of innovative medical devices in China to obtain a medical device registration certificate for VR-based brain diseases, filling multiple clinical gaps in China's digital mental healthcare field. These products deeply integrate brain science, AI algorithms, VR/XR, and BCI-like technologies, transforming traditional psychological and cognitive diagnosis and treatment into low-threshold, highly immersive interactive experiences. Through diverse scenario designs such as forest therapy, safe social simulation, and cognitive rehabilitation, they cover the full spectrum of treatment and rehabilitation for various brain diseases and mental disorders, including anxiety disorder, phobias, depression, autism, and cognitive impairment. Meanwhile, the system can collect multimodal physiological data such as heart rate, eye-tracking, and emotional feedback in real-time during the diagnostic and treatment process, automatically generating precise visualized diagnostic reports. This provides comprehensive data support for medical professionals to formulate personalized treatment plans, constructing a full-process diagnostic and treatment closed loop of "immersive intervention - data-driven assessment - personalized optimization."
To date, these products have achieved clinical application in thousands of hospitals across China and have been deeply implemented in the Hainan Boao Lecheng International Medical Tourism Pilot Zone. Several Grade III-A hospitals in Hainan Province, including Hainan Provincial People's Hospital, Hainan Provincial Anning Hospital, The Second Affiliated Hospital of Hainan Medical University, Hainan Provincial Pingshan Hospital, and Danzhou Maternal and Child Health Care Hospital, have adopted NEUREAL-related product services. Leveraging the policy advantages and open platform of the Hainan Free Trade Port, the company is accelerating the internationalization of its products and the expansion of cross-border healthcare scenarios.
Deepening Expertise in Brain Science to Drive Digital Healthcare Development
Since its inception, NEUREAL has consistently focused on brain science and digital brain disease diagnosis and treatment, building a complete product system for brain disease treatment and rehabilitation covering multiple disciplines such as psychiatry, neurology, and rehabilitation. With sustained original technological innovation and large-scale clinical implementation capabilities, it remains firmly in the first tier of the domestic digital mental healthcare sector. At the end of 2025, the company completed an A+ round of financing exceeding 50 million yuan, with its technological strength and commercialization capabilities continuously receiving dual recognition from capital markets and the clinical industry.
This appearance at the 25th Anniversary Annual Conference of the Boao Forum for Asia is not only a major showcase of NEUREAL's core medical innovation achievements for global political, business, and academic leaders but also an important window for Chinese digital healthcare technology to enter the world stage. In the future, NEUREAL will take this forum as an opportunity to continue deepening core technological innovations and clinical translations in BCI and AI. Relying on the global cooperation platform of the Boao Forum for Asia, it will actively connect with high-quality international resources, promote the global implementation of China's original digital healthcare technologies and products, empower the high-quality development of global healthcare through scientific and technological innovation, and contribute Chinese wisdom and Chinese solutions to shaping a shared healthy future for humanity.
